3 Years Later: COVID-19 and Cancer Series
In this two-part webinar series, participants will learn how to navigate a cancer diagnosis post-COVID, including strategies to minimize the risk of infection. The series will cover telemedicine, mental health, and staying safe during treatment.
Part I: COVID-19 and Cancer
This 60-minute webinar will provide an overview of many changes that have impacted the cancer community over the last three years. Although the world continues to move towards normalcy, many people continue to be at risk due to compromised immune systems. Join us to learn more about how to cope with cancer in a post-pandemic world.
Part II: Navigating the Risk of Infections Post-COVID
In partnership with Sepsis Alliance, this workshop provides information and discusses navigating infections in a post-pandemic world.
Dr. Cindy Hou will provide information on how to navigate infections in a post-pandemic world.
Cindy Hou, DO, MA, MBA, CIC, CPHQ, FACOI, FACP, FIDSA, is the Infection Control Officer and Medical Director of Research at Jefferson Health, New Jersey. She is also the Chief Medical Officer at Sepsis Alliance.
Infections, especially those caused by AMR (or antimicrobial resistance) can cause many complications for those affected by cancer. Don't be fooled by the long name – antimicrobial resistance is when bacteria, viruses and other microorganisms become resistant to the drugs that are supposed to kill them or stop them from growing.
Why is this important for people diagnosed with cancer? Because infections caused by these microorganisms can be more difficult or even impossible to treat which leads to longer hospital stays, increased healthcare costs and sometimes even death. Think of it like a "superpower" that the microorganisms develop to protect themselves from drugs that are designed to kill them.
Watch this Webinar
This Coping Circle Workshop Series is sponsored by Pfizer.